99 related articles for article (PubMed ID: 19127106)
21. Isodicentric 20q- in two cases of B-cell acute lymphocytic leukemia with the respective t(9;20)(p11;q11.2) and t(9;22)(q34;q11.2).
Li T; Xue Y; Zhang J; Chen S; Pan J; Wu Y; Wang Y; Shen J
Cancer Genet Cytogenet; 2008 Feb; 181(1):55-9. PubMed ID: 18262055
[TBL] [Abstract][Full Text] [Related]
22. Synovial sarcoma of the lung in a patient who received radioactive iodine therapy for thyroid cancer.
Vora A; Schneider AB
Thyroid; 2013 Mar; 23(3):371-5. PubMed ID: 23205908
[TBL] [Abstract][Full Text] [Related]
23. Behcet's disease associated with malignancy: a report of 41 Chinese cases.
Lin Y; Li G; Zheng W; Tian X; Zhang F
Int J Rheum Dis; 2014 May; 17(4):459-65. PubMed ID: 24354961
[TBL] [Abstract][Full Text] [Related]
24. T-cell acute lymphoblastic leukemia as a secondary leukemia after a 3-year remission of acute myelocytic leukemia.
Tsuboi K; Komatsu H; Miwa H; Iida S; Banno S; Wakita A; Nitta M; Ueda R
Int J Hematol; 2003 Jun; 77(5):518-21. PubMed ID: 12841392
[TBL] [Abstract][Full Text] [Related]
25. Unbalanced 11;18 translocation in an acute erythroid leukemia after radioactive iodine therapy.
Trikalinos NA; Chen Q; Ning Y; Sausville EA; Baer MR
Cancer Genet; 2013 Jun; 206(6):252-5. PubMed ID: 23871646
[TBL] [Abstract][Full Text] [Related]
26. Therapy-related leukemia following chemoradiotherapy for esophageal cancer.
Mimura N; Tsujimura H; Ise M; Sakai C; Takagi T; Nagata M; Kumagai K
Eur J Haematol; 2010 Oct; 85(4):353-7. PubMed ID: 20546022
[TBL] [Abstract][Full Text] [Related]
27. Systemic mastocytosis with associated clonal hematological non-mast-cell lineage disease: analysis of clinicopathologic features and activating c-kit mutations.
Pullarkat VA; Bueso-Ramos C; Lai R; Kroft S; Wilson CS; Pullarkat ST; Bu X; Thein M; Lee M; Brynes RK
Am J Hematol; 2003 May; 73(1):12-7. PubMed ID: 12701114
[TBL] [Abstract][Full Text] [Related]
28. Multicolour FISH detection of radioactive iodine-induced 17cen-p53 chromosomal breakage in buccal cells from therapeutically exposed patients.
Ramírez MJ; Puerto S; Galofré P; Parry EM; Parry JM; Creus A; Marcos R; Surrallés J
Carcinogenesis; 2000 Aug; 21(8):1581-6. PubMed ID: 10910962
[TBL] [Abstract][Full Text] [Related]
29. t(1;3)(p36;p21) is a recurring therapy-related translocation.
Sato Y; Izumi T; Kanamori H; Davis EM; Miura Y; Larson RA; Le Beau MM; Ozawa K; Rowley JD
Genes Chromosomes Cancer; 2002 Jun; 34(2):186-92. PubMed ID: 11979552
[TBL] [Abstract][Full Text] [Related]
30. Chronic myeloid leukemia after treatment with 131 for thyroid carcinoma.
Wang KL; Lin LY; Chen PM; Lin HD
J Chin Med Assoc; 2005 May; 68(5):230-3. PubMed ID: 15909729
[TBL] [Abstract][Full Text] [Related]
31. Identification of new partner chromosomes involved in fusions with the ETV6 (TEL) gene in hematologic malignancies.
Tosi S; Giudici G; Mosna G; Harbott J; Specchia G; Grosveld G; Privitera E; Kearney L; Biondi A; Cazzaniga G
Genes Chromosomes Cancer; 1998 Mar; 21(3):223-9. PubMed ID: 9523197
[TBL] [Abstract][Full Text] [Related]
32. Therapy-related myelodysplastic syndrome and acute myeloid leukemia in patients with chronic lymphocytic leukemia treated with fludarabine and cyclophosphamide.
Colović M; Suvajdžić N; Janković G; Tomin D; Colović N; Fekete MD; Palibrk V
Biomed Pharmacother; 2011 Aug; 65(5):319-21. PubMed ID: 21775097
[TBL] [Abstract][Full Text] [Related]
33. [Clinical characteristics and prognosis of 35 patients with therapy-related hematological neoplasms].
Lu QS; Xu N; Zhou X; Cai GX; Li L; Li YL; Lu ZY; Huang JX; Liu QF; Liu XL
Zhonghua Xue Ye Xue Za Zhi; 2016 Mar; 37(3):221-6. PubMed ID: 27033760
[TBL] [Abstract][Full Text] [Related]
34. Therapy-related acute leukemia with mixed phenotype and t(9;22)(q32;q11.2): a case report and review of the literature.
Cho JH; Hur M; Moon HW; Yun YM; Ko YS; Kim WS; Lee MH
Hum Pathol; 2012 Apr; 43(4):605-9. PubMed ID: 22036054
[TBL] [Abstract][Full Text] [Related]
35. [Rearrangements of chromosome 9 in different hematological neoplasia].
Andreeva SV; Drozdova VD; Ponochevnaia EV; Kavardakova NV
Tsitol Genet; 2008; 42(5):72-9. PubMed ID: 19140443
[TBL] [Abstract][Full Text] [Related]
36. [Cytogenetics and clinical studies of hematologic malignancies with 11q23 abnormalities in China].
Guo Y; Xue Y; Xie X; Wu D; Li J; Lu D; Jiang F; Geng M
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Apr; 17(2):72-5. PubMed ID: 10751523
[TBL] [Abstract][Full Text] [Related]
37. Cytogenetic polyclonality in hematologic malignancies.
Johansson B; Billström R; Broberg K; Fioretos T; Nilsson PG; Ahlgren T; Malm C; Samuelsson BO; Mitelman F
Genes Chromosomes Cancer; 1999 Mar; 24(3):222-9. PubMed ID: 10451702
[TBL] [Abstract][Full Text] [Related]
38. Translocation (7;9)(q22;q34) in therapy-related myelodysplastic syndrome after allogeneic bone marrow transplantation for acute myeloblastic leukemia.
Yamamoto K; Yakushijin K; Kawamori Y; Minagawa K; Katayama Y; Matsui T
Cancer Genet Cytogenet; 2007 Jul; 176(1):61-6. PubMed ID: 17574966
[TBL] [Abstract][Full Text] [Related]
39. Second primary malignancy risk after radioactive iodine treatment for thyroid cancer: a systematic review and meta-analysis.
Sawka AM; Thabane L; Parlea L; Ibrahim-Zada I; Tsang RW; Brierley JD; Straus S; Ezzat S; Goldstein DP
Thyroid; 2009 May; 19(5):451-7. PubMed ID: 19281429
[TBL] [Abstract][Full Text] [Related]
40. [Long-term hematologic changes caused by radioiodine treatment of thyroid cancer. I. Peripheral blood changes].
Schober O; Günter HH; Schwarzrock R; Hundeshagen H
Strahlenther Onkol; 1987 Jul; 163(7):464-74. PubMed ID: 3616905
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
